Efficacy and safety of dabigatran and rivaroxaban in atrial fibrillation patients with impaired liver function: a multicenter retrospective cohort study-Reference-Cited by-同舟云学术

Efficacy and safety of dabigatran and rivaroxaban in atrial fibrillation patients with impaired liver function: a multicenter retrospective cohort study

Published:2024-04-12 Issue:8 Volume:80 Page:1141-1150
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Huang Xinhai,Xu Wenlin,Wu Guilan,Li Ruijuan,Gu Ping,Zheng Qiaowei,Liu Xiumei,Dai Hengfen,Lin Xiangsheng,Liu Yuxin,Du Xiaoming,Su Jun,Zhang Wang,Zhang Min,Zhu Zhu,Huang Xiaohong,Huang Nianxu,Zhang Jinhua^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00228-024-03689-3.pdf

Reference34 articles.

1. Huang ZC, Li CQ, Liu XY et al (2021) Efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation and liver disease: a meta-analysis and systematic review. Cardiovasc Drugs Ther 35(6):1205–1215

2. Chugh SS, Havmoeller R, Narayanan K et al (2014) Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation 129(8):837–847

3. Vizzardi E, Curnis A, Latini MG et al (2014) Risk factors for atrial fibrillation recurrence: a literature review. J Cardiovasc Med (Hagerstown) 15(3):235–253

4. Joglar JA, Chung MK, Armbruster AL (2024) 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines [published correction appears in Circulation. 2024 Jan 2;149(1):e167] [published correction appears in Circulation. 2024 Feb 27;149(9):e936]. Circulation 149(1):e1–e156

5. Ferri N, Colombo E, Tenconi M et al (2022) Drug-drug interactions of direct oral anticoagulants (DOACs): from pharmacological to clinical practice. Pharmaceutics 14(6):1120 Published 2022 May 24